ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2667

Whole Frequency Audiometrical Correlation with Disease Activity in Primary SjöGren’s Syndrome in Hispanic Population

Janett Riega-Torres1, Yolisa Hinojosa-Rios2, Jose Luis Treviño-González2, Lorena Pérez-Barbosa3, Mario Alberto Garza-Elizondo4, David Vega-Morales5, Amaury Valdés-Mancha6, Jorge Esquivel-Valerio4, Mario Jesus Villegas-Gonzalez2, Cassandra Skinner-Taylor3 and Diana Flores-Alvarado7, 1Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Servicio de Otorrinolaringología y Cirugía de Cabeza y Cuello. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Hospital Universitario, Monterrey, Mexico, 4Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 5Universidad Autónoma de Nuevo Léon, Monterrey, Mexico, 6Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 7Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity and Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Sjögren's Syndrome - Poster II: Clinical Science

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Sjögren’s syndrome is an autoimmune disorder that can develop hearing loss, It can be diagnosed with high frequency audiometry. Our study aims to correlate the hearing according to the level of disease activity, using the EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) as an evaluation tool and performing high frequency audiometry and tympanogram in a population with primary Sjögren’s syndrome.

Methods:

The audiological evaluation were performed by the same experienced audiologist in an Acoustic Systems soundproof chamber with calibration, model RE-142 manufactured in U.S.A, and Interacustic AC40 audiometer (125-16,000Hz frequencies with bone conduction thresholds at 500-4000Hz frequencies). Pure-tone speech audiometries were conducted measuring speech discrimination thresholds and word recognition. Tympanometry (Audiotest 425 h Interacustic) with acoustic reflex and static acoustic compliance for both ears were tested. Tympanometry was considered normal with middle ear pressures of ± 75 da Pa (deca Pascal: unit of pressure) with compliance of 0.28-1.5ml, and the presence of acoustic reflex when it occurred with stimulation at 70-95 dB in 500; 1000; 2000; and 4000Hz. The tympanograms were classified according to Jerger as types A, As, Ad, B, and C. Hearing loss was accepted if the hearing threshold was 20 dB or higher than 20dB. 

Results: A total of 76 patients, 3(3.9%) male and 73(96.1%) women were recruited. The median age was 52.5 years. The disease activity was reported as mild in 23(30.3%) patients, moderate in 28(36.8%) and severe in 25(32.9%). The Pure Tone Average (PTA) in the right ear was 18.72dB (SD11.6) and left ear 20.72dB (SD12.19) in the frequency range 500 to 3000Hz. The comparison between the degree of illness and right and left PTA was P=0.399 and P=0.359 respectively. The PTA in the frequency range 4000 to 8000Hz in the right ear was 29.34dB (SD5.18) and the left ear was 31.40dB (SD17.68), P=0.198 and P=0.115 respectively. The PTA in the frequency range 10000-16000Hz was in the right ear 55.82dB (SD18.10) and the left ear was 55.17dB (SD19.58), P=0.134 and P=0.180, respectively. The prevalence of hearing loss in patients with primary Sjögren’s syndrome in high frequencies (10,000-16,000) in the right ear was 62(94.7%) and the left ear 69(90.8%). No significant differences between the degree of disease activity and the level of hearing in patients with primary Sjögren’s syndrome were found.

Conclusion:

Despite the high prevalence of hearing loss of high frequencies in this cohort of Sjögren’s Syndrome Patients, we observed no correlation with disease activity

Table 1. Pure Tone Average and standard deviation 

Test frequency (Hz)

Right ear

Left ear

500-3,000

18.72 ±11.6 

20.72 ±12.19

4,000-8,000

29.34 ±5.18 

31.40 ±17.68

10,000-16,000

55.82 ±18.10 

55.17 ±19.58

Table 2. Mean PTA comparison with ESSPRI using Kruskal-Wallis test 

Frequency range

Mean PTA (SD)

P

Right Ear

500-3,000

Mild

Moderate

Severe

21.19 (20.08) 

16.98 (8.32)

18.90 (7.05)

0.399

4,000-8,000

Mild

Moderate

Severe

29.83 (23.95)

26.01 (15.61)

33.07 (16.94)

0.198

10,000-16,000

Mild

Moderate

Severe

 

56.37 (19.53)

51.57 (19.93)

60.65 (13.30

0.134 

Left Ear

500-3,000

Mild

Moderate

Severe

19.88 (11.22)

21.05 (14.31)

21.00 (8.02)

0.359

4,000-8,000

Mild

Moderate

Severe

27.92 (16.69)

30.11 (19.65)

35.80 (15.55)

0.115

10,000-16,000

Mild

Moderate

Severe

52.87 (18.05)

51.69 (22.71)

61.32 (15.38)

0.180

Table 3. Prevalence of Hearing loss in primary Sjögren´s syndrome in Hispanic 

population 

Test frequency (Hz)

Number of patients N=76 (%)

Right ear

500-3,000

8 (10.5)

4,000-8,000

32 (42.1)

10,000-16,000

Left ear

500-3,000 

62 (94.7)

18 (23.7) 

4,000-8,000

41 (53.9)

10,000-16,000

69 (90.8)


Disclosure: J. Riega-Torres, None; Y. Hinojosa-Rios, None; J. L. Treviño-González, None; L. Pérez-Barbosa, None; M. A. Garza-Elizondo, None; D. Vega-Morales, None; A. Valdés-Mancha, None; J. Esquivel-Valerio, None; M. J. Villegas-Gonzalez, None; C. Skinner-Taylor, None; D. Flores-Alvarado, None.

To cite this abstract in AMA style:

Riega-Torres J, Hinojosa-Rios Y, Treviño-González JL, Pérez-Barbosa L, Garza-Elizondo MA, Vega-Morales D, Valdés-Mancha A, Esquivel-Valerio J, Villegas-Gonzalez MJ, Skinner-Taylor C, Flores-Alvarado D. Whole Frequency Audiometrical Correlation with Disease Activity in Primary SjöGren’s Syndrome in Hispanic Population [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/whole-frequency-audiometrical-correlation-with-disease-activity-in-primary-sjogrens-syndrome-in-hispanic-population/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/whole-frequency-audiometrical-correlation-with-disease-activity-in-primary-sjogrens-syndrome-in-hispanic-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology